Worcester, Mass.
BASF Bioresearch Corp. (BBC) has begun a $37 million construction project at its facility near the Worcester Biotechnology Park. The existing 365,000-sf structure will undergo the addition of 6,600 sf of warehouse space and the conversion of 36,800 sf to office and space to manufacture the pharmaceutical company's arthritis drug. Completion of the project is scheduled for June 2001. BBC is the biotech unit of BASF Pharma, which is a subsidiary of BASF AG.
